Morteza Alipour

Morteza Alipour

Auto-generated profile, based on publicly available information

Morteza Alipour

University of Tehran, Tehran, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2026 in Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
FNFatemeh Nouroozi
Fatemeh Nouroozi
HKHelia Sadat Kazemi
Helia Sadat Kazemi
AAArmin Alinezhad
Armin Alinezhad
NGnooshin goudarzi
nooshin goudarzi
MKMohammad Kian Khosravi
Mohammad Kian Khosravi
ERElina Rostami
Elina Rostami
Neuropsychiatric systemic lupus erythematosus (NPSLE) remains challenging to diagnose because of heterogeneous clinical presentations, nonspecific findings, and the absence of definitive biomarkers. Artificial intelligence (AI) methods have been increasingly explored using neuroimaging and other biologically informative data to support identification of neuropsychiatric involvement in systemic lupus erythematosus (SLE). However, the reported performance and methodological robustness of these approaches have not been systematically characterized. To perform an exploratory meta-analysis describing reported diagnostic performance, heterogeneity, and methodological characteristics of AI-based models using neuroimaging and multimodal biomarkers for detecting neuropsychiatric involvement in SLE. We conducted a PRISMA-compliant systematic review of studies applying machine learning or deep learning models to neuroimaging or biologically informative modalities relevant to central nervous system involvement, including structural or functional MRI, magnetic resonance spectroscopy, spectroscopy-based molecular fingerprints, and CSF or serum biomarkers. PubMed, Scopus, and Web of Science were searched through August 2025. Given substantial heterogeneity in study design, model objectives, input modalities, and validation strategies, analyses were undertaken within an exploratory framework. Random-effects models were used to summarize reported area under the curve (AUC), accuracy, sensitivity, and specificity. Subgroup and leave-one-out sensitivity analyses were performed. Fourteen studies involving more than 800 participants were included. Most studies used neuroimaging, particularly resting-state functional MRI, while others incorporated non-imaging biomarkers. Reported performance metrics were generally high (pooled AUC 0.86; accuracy 0.87), but between-study heterogeneity was substantial. Sensitivity analyses demonstrated that pooled estimates were unstable and influenced by individual studies. No clear performance differences were observed between classical machine learning and deep learning approaches. External validation and formal explainable AI methods were uncommon. This exploratory synthesis indicates that AI-based models applied to neuroimaging and multimodal biomarkers have shown promising reported performance in NPSLE. However, marked heterogeneity, limited robustness, and poor interpretability currently preclude firm conclusions regarding clinical applicability. More standardized, externally validated, and interpretable studies are needed before translation into clinical practice.

1 January 2026 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
MAMorteza Alipour
Morteza Alipour
RBReihaneh Bonyad
Reihaneh Bonyad
SGShamila Ghasemi
Shamila Ghasemi
PKParisa Khoshdooz
Parisa Khoshdooz
FSFatemeh Shafiee
Fatemeh Shafiee
MHMeysam Hasannejad-Bibalan
Meysam Hasannejad-Bibalan
Background: The skin microbiome plays a central role in maintaining barrier integrity, immune regulation, and overall skin health. Disruption of this complex microbial ecosystem is increasingly associated with dermatological disorders such as acne, atopic dermatitis, and photoaging. In recent years, probiotics and postbiotics have emerged as promising cosmetic and dermatological interventions for restoring microbial balance and enhancing skin function. Probiotics, when administered orally or topically, demonstrate benefits including reduced acne lesions, improved hydration, wrinkle reduction, and modulation of systemic and local immune responses. Postbiotics, defined as nonviable microorganisms or their metabolites, offer additional advantages such as superior stability, safety, and regulatory feasibility. Methods: In this narrative review, a targeted search was performed across multiple databases to identify relevant articles, from which the key relationships and strategies were extracted. Then, we represented the findings to provide a comprehensive overview of the topic and highlight emerging trends and gaps in the literature. Results: Evidence from randomized controlled trials highlights their efficacy in improving skin hydration, elasticity, and dermal density while reducing transepidermal water loss and oxidative stress. Mechanistically, bioactive metabolites including short‐chain fatty acids, peptides, exopolysaccharides, and sphingomyelinase promote ceramide synthesis, antioxidant defense, and antimicrobial protection. Regulatory frameworks differ across regions, yet the global market increasingly favors microbiome‐friendly and postbiotic‐containing formulations. Future innovations are expected to move toward personalized and precision skincare through microbiome profiling, engineered microbial strains, and synbiotic formulations. Conclusion: Collectively, probiotics and postbiotics represent a new frontier in cosmetic dermatology, combining efficacy with safety to advance next‐generation skincare solutions.

31 October 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
AZAref Zarei
Aref Zarei
HMHadis Malekpour
Hadis Malekpour
MNMahya Naghipoor-Alamdari
Mahya Naghipoor-Alamdari
MMMahtab Mirbolook
Mahtab Mirbolook
ANAmin Nematian
Amin Nematian
AMAmirhossein Mallahi
Amirhossein Mallahi
Cone-beam computed tomography (CBCT) is widely used in oral and maxillofacial practice, yet interpretation can be challenging because of anatomical complex

15 March 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
MEMohammad Erabi
Mohammad Erabi
MRMohammadreza Rahmani
Mohammadreza Rahmani
BMBahareh Mahdianfar
Bahareh Mahdianfar
PEPooya Eini
Pooya Eini
AAAida Azhdarimoghaddam
Aida Azhdarimoghaddam
ANAysuda Nakhjavanlou
Aysuda Nakhjavanlou
Percutaneous coronary intervention (PCI) is a cornerstone of coronary artery disease management, yet predicting post-procedural outcomes remains challengin

8 October 2025 in Burns
Verified
Journal Article
Closed access
MAMorteza Alipour
Morteza Alipour
AJAmirhossein Jafari
Amirhossein Jafari
MFMohammad Javad Tabatabaei Fallah
Mohammad Javad Tabatabaei Fallah
ZJZakiyeh Jafaryparvar
Zakiyeh Jafaryparvar